abs268.txt	we	describe	two	cases	of	patients	with	hepatitis	c	virus	(hcv)	treated	withdirect-acting	antiviral	(daa)	therapy	who	had	dramatic	improvement	inhepatocellular	carcinoma	(hcc)	tumor	burden	with	daa	therapy	alone		both	patientswere	diagnosed	with	hcc	on	screening	magnetic	resonance	imaging	shortly	afterbeginning	daa	therapy		both	patients	achieved	sustained	virologic	response	(svr)with	dramatic	improvement	in	hcc	tumor	burden	on	follow-up	imaging	without	hcctreatment		patients	with	multifocal	or	advanced	hcc	are	infrequently	treated	withantiviral	therapy	for	hcv		as	a	result		these	cases	provide	unique	insight	intothe	ongoing	debate	regarding	the	impact	of	svr	on	existing	and	recurrent	hcc		wereview	the	current	literature	regarding	this	debate		as	well	as	the	theory	ofimmunosurveillance		we	postulate	that	daa	therapy	activates	cd8+	t	cells	toinduce	a	t-cell-mediated	response	and	increased	immunosurveillance	tovirus-induced	liver	cancer	
